Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Baxter International Inc.    BAX

BAXTER INTERNATIONAL INC.

(BAX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/17/2020 11/18/2020 11/19/2020 11/20/2020 11/23/2020 Date
80.78(c) 80.42(c) 78.88(c) 77.02(c) 75.77(c) Last
3 877 198 3 946 100 2 622 816 2 878 806 3 049 489 Volume
-0.25% -0.45% -1.91% -2.36% -1.62% Change
More quotes
Financials (USD)
Sales 2020 11 541 M - -
Net income 2020 1 338 M - -
Net Debt 2020 1 667 M - -
P/E ratio 2020 29,0x
Yield 2020 1,22%
Sales 2021 12 133 M - -
Net income 2021 1 748 M - -
Net Debt 2021 541 M - -
P/E ratio 2021 23,0x
Yield 2021 1,36%
Capitalization 38 705 M 38 705 M -
EV / Sales 2020 3,50x
EV / Sales 2021 3,23x
Nbr of Employees 50 000
Free-Float 74,6%
More Financials
Company
Baxter International specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - kidney dialysis drugs and equipment (52.1%); - systems for delivering medications and intravenous therapy (24.6%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral... 
More about the company
Notations Surperformance© of Baxter International Inc.
Trading Rating : Investor Rating :
More Ratings
All news about BAXTER INTERNATIONAL INC.
08:44aBAXTER INTERNATIONAL : Announces U.S. FDA 510(k) Clearance of Homechoice Claria ..
AQ
08:06aBAXTER INTERNATIONAL : BioPharma Solutions Announces $50 Million Investment to E..
BU
11/23BAXTER INTERNATIONAL : Announces U.S. FDA 510(k) Clearance of Homechoice Claria ..
BU
11/20BAXTER INTERNATIONAL INC : Change in Directors or Principal Officers, Financial ..
AQ
11/19BAXTER INTERNATIONAL : to Present at the Evercore ISI 3rd Annual HealthCONx Virt..
AQ
11/18BAXTER INTERNATIONAL : to Present at the Evercore ISI 3rd Annual HealthCONx Virt..
BU
11/17BAXTER INTERNATIONAL : Declares Quarterly Dividend
AQ
11/17BAXTER INTERNATIONAL : Publishes its First Sustainability Accounting Standards B..
AQ
11/16BAXTER INTERNATIONAL : Declares Quarterly Dividend
BU
11/16BAXTER INTERNATIONAL : Publishes Its First Sustainability Accounting Standards B..
BU
11/06BAXTER INTERNATIONAL : Lowers Full-Year GAAP EPS Guidance -- Update
DJ
11/06BAXTER INTERNATIONAL : Lowers Full-Year EPS Guidance
DJ
11/06BAXTER INTERNATIONAL INC : Entry into a Material Definitive Agreement, Creation ..
AQ
10/30BAXTER INTERNATIONAL : Reports Third-Quarter 2020 Results
AQ
10/30BAXTER INTERNATIONAL : Announces Proposed $650 Million Senior Notes Offering
AQ
More news
News in other languages on BAXTER INTERNATIONAL INC.
10/29Morning Briefing - International Teil 1
10/28TAGESVORSCHAU : Termine am 29. Oktober 2020
10/26BAXTER INTERNATIONAL INC. : publication des résultats trimestriels
10/26BAXTER INTERNATIONAL INC. : Veröffentlichung des Quartalsergebnisses
10/16BAXTER INTERNATIONAL : soutient une nouvelle étude montrant les besoins nutritio..
More news
Analyst Recommendations on BAXTER INTERNATIONAL INC.
More recommendations
Chart BAXTER INTERNATIONAL INC.
Duration : Period :
Baxter International Inc. Technical Analysis Chart | BAX | US0718131099 | MarketScreener
Technical analysis trends BAXTER INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Average target price 92,82 $
Last Close Price 75,77 $
Spread / Highest target 38,6%
Spread / Average Target 22,5%
Spread / Lowest Target -3,66%
EPS Revisions
Managers
NameTitle
José E. Almeida Chairman, President & Chief Executive Officer
James K. Saccaro Chief Financial Officer & Executive Vice President
Sumant Ramachandra Senior VP, Chief Science & Technology Officer
Tobi Karchmer Vice President-Worldwide Medical
Talvis Love Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
BAXTER INTERNATIONAL INC.-9.39%38 705
ABBOTT LABORATORIES25.80%193 666
MEDTRONIC PLC-2.19%149 189
BECTON, DICKINSON AND COMPANY-15.99%66 229
HOYA CORPORATION25.50%44 928
ALIGN TECHNOLOGY, INC.70.79%37 579